companies developing glp-1 receptor agonists Agonist Market Size, Share Global GLP-1 Receptor Agonist Market
Description
Questions and Answers - Safety Requirements for Victoza (liraglutide)
(2025, August 6)
14 Jardiance Side Effects & What to Do About Them Key Takeaways Jardiance (empagliflozin) is an SGLT2 inhibitor used to treat type 2 diabetes and can also help prevent complications from heart failure and chronic kidney disease
[DOI] [PubMed] [Google Scholar] 37.Drucker D.J., Buse J.B., Taylor K., Kendall D.M., Trautmann M., Zhuang D., Porter L., DURATION-1 Study Group Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study
